A Fourth IκB Protein within the NF-κB Signaling Module

An assay method incorporating at least two different chemiluminescent compounds for detection and/or quantitation of at least two substances in a test sample is described. The synthesis of chemiluminescent reagents or conjugates for use in such methods as well as kits incorporating such reagents are also disclosed. The assays have particular application in the field of clinical diagnostics.

[1]  David Baltimore,et al.  Genetic analysis of NF‐κB/Rel transcription factors defines functional specificities , 2003, The EMBO journal.

[2]  T. Okamoto,et al.  The NF-kappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536. , 2003, The Journal of biological chemistry.

[3]  T. Serikawa,et al.  Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. , 1999, Nature genetics.

[4]  S. Ley,et al.  Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. , 2004, The Biochemical journal.

[5]  E. Harhaj,et al.  NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. , 2001, Molecular cell.

[6]  P. Ramakrishnan,et al.  Receptor-Specific Signaling for Both the Alternative and the Canonical NF-κB Activation Pathways by NF-κB-Inducing Kinase , 2004 .

[7]  M. Karin,et al.  p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction. , 1993, Genes & development.

[8]  D. Baltimore,et al.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor. , 1988, Science.

[9]  F. Mackay,et al.  Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. , 1998, Immunity.

[10]  I. Verma,et al.  Distinct roles of IκB proteins in regulating constitutive NF-κB activity , 2005, Nature Cell Biology.

[11]  Jürgen R. Müller,et al.  Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways. , 2003, The Journal of biological chemistry.

[12]  N. Hacohen,et al.  Requirement for the NF-κB Family Member RelA in the Development of Secondary Lymphoid Organs , 2002, The Journal of experimental medicine.

[13]  P. Ramakrishnan,et al.  Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase. , 2004, Immunity.

[14]  J. Sprent,et al.  Regulation of naive T cell function by the NF-kappaB2 pathway. , 2006, Nature immunology.

[15]  Alexander Hoffmann,et al.  IκBɛ provides negative feedback to control NF-κB oscillations, signaling dynamics, and inflammatory gene expression , 2006, The Journal of cell biology.

[16]  M. Karin,et al.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. , 2001, Science.

[17]  T. Okamoto,et al.  The NF-κB Activation in Lymphotoxin β Receptor Signaling Depends on the Phosphorylation of p65 at Serine 536* , 2003, The Journal of Biological Chemistry.

[18]  S. Akira,et al.  Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ , 2004, Nature.

[19]  D. Green,et al.  RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100. , 2003, The Journal of biological chemistry.

[20]  R. Mebius.  Organogenesis of lymphoid tissues , 2003, Nature reviews. Immunology.

[21]  E. Harhaj,et al.  NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100 , 2001 .

[22]  Wei Wang,et al.  Identification of Novel Protein-Protein Interactions Using A Versatile Mammalian Tandem Affinity Purification Expression System* , 2003, Molecular & Cellular Proteomics.

[23]  I. Verma,et al.  I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family. , 1992, Cell.

[24]  J. Sprent,et al.  Regulation of naive T cell function by the NF-κB2 pathway , 2006, Nature Immunology.

[25]  B. Dörken,et al.  Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells , 1999, Oncogene.

[26]  S. Akira,et al.  Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. , 2004, Nature.

[27]  D. Green,et al.  RelB/p50 dimers are differentially regulated by TNF-α and lymphotoxin-β receptor activation: critical roles for p100 , 2003 .

[28]  G. Ghosh,et al.  p105·IκBγ and Prototypical IκBs Use a Similar Mechanism to Bind but a Different Mechanism to Regulate the Subcellular Localization of NF-κB* , 2003, The Journal of Biological Chemistry.

[29]  G. Ghosh,et al.  The 20S proteasome processes NF‐κB1 p105 into p50 in a translation‐independent manner , 2006, The EMBO journal.

[30]  Jürgen R. Müller,et al.  Lymphotoxin β Receptor Induces Sequential Activation of Distinct NF-κB Factors via Separate Signaling Pathways* , 2003, The Journal of Biological Chemistry.

[31]  T. Hara,et al.  Lymph Node Fibroblastic Reticular Cells Construct the Stromal Reticulum via Contact with Lymphocytes , 2004, The Journal of experimental medicine.

[32]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[33]  A. Hoffmann,et al.  I kappa B epsilon provides negative feedback to control NF-kappa B oscillations, signaling dynamics, and inflammatory gene expression , 2006 .

[34]  J. Caamaño,et al.  Regulation of secondary lymphoid organ development by the nuclear factor‐κB signal transduction pathway , 2003, Immunological reviews.

[35]  S. Perrin,et al.  Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. , 2005, Immunity.

[36]  B. Mordmüller,et al.  Lymphotoxin and lipopolysaccharide induce NF‐κB‐p52 generation by a co‐translational mechanism , 2003, EMBO reports.

[37]  D. Green,et al.  The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. , 2002, Immunity.

[38]  C. Scheidereit,et al.  The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  B. Aronow,et al.  Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers , 2004 .

[40]  A. Hoffmann,et al.  Circuitry of nuclear factor kappaB signaling. , 2006, Immunological reviews.

[41]  D. Green,et al.  The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways , 2002 .

[42]  A. Hoffmann,et al.  Coordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues. , 2006, Blood.

[43]  C. Scheidereit,et al.  NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors. , 1993, Oncogene.

[44]  I. Verma,et al.  Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity. , 2005, Nature cell biology.

[45]  I. Verma,et al.  IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: A new member of the IκB family , 1992, Cell.

[46]  Michael Karin,et al.  The IKK NF-kappa B system: a treasure trove for drug development. , 2004, Nature reviews. Drug discovery.

[47]  G. Ghosh,et al.  p105.Ikappa Bgamma and prototypical Ikappa Bs use a similar mechanism to bind but a different mechanism to regulate the subcellular localization of NF-kappa B. , 2003, Journal of Biological Chemistry.

[48]  B. Aronow,et al.  Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. , 2004, The EMBO journal.

[49]  S. Perrin,et al.  Lymphotoxin-β Receptor Signaling Is Required for the Homeostatic Control of HEV Differentiation and Function , 2005 .

[50]  F. Weih,et al.  Essential Role of RelB in Germinal Center and Marginal Zone Formation and Proper Expression of Homing Chemokines1 , 2001, The Journal of Immunology.

[51]  C. Ware,et al.  Lymphotoxin and LIGHT signaling pathways and target genes , 2004, Immunological reviews.

[52]  Michael Karin,et al.  Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.

[53]  T. Serikawa,et al.  Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κb-inducing kinase , 1999, Nature Genetics.

[54]  F. Mackay,et al.  Lymph Node Genesis Is Induced by Signaling through the Lymphotoxin β Receptor , 1998 .

[55]  S. Ley,et al.  Functions of NF-?B1 and NF-?B2 in immune cell biology , 2004 .

[56]  A. Hoffmann,et al.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.

[57]  A. Hoffmann,et al.  Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways. , 2004, Proceedings of the National Academy of Sciences of the United States of America.